Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DADIDA trial of daiobotanpito added to standard treatment for acute diverticulitis
jRCTs041180063Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in diverticulitis comparing Standard Treatment + Placebo with Standard Treatment + daiobotanpito (2 arms). Primary endpoint: Treatment success rate. Started Mar 2018; status: active, not recruiting.
02
Drugs
daiobotanpito
03
Conditions
diverticulitis
Beyond the preview
Go deeper on jRCTs041180063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180063.